• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用间充质干细胞和黄芩苷联合治疗肝纤维化的新型治疗方案。

A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin.

作者信息

Qiao Hongxiang, Tong Yinghui, Han Hongcan, Xu Wei, Ren Zihua, Ouyang Jingfeng, Chen Yan

机构信息

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

出版信息

Pharmazie. 2011 Jan;66(1):37-43.

PMID:21391433
Abstract

Baicalin, isolated from the root of Scutellaria baicalensis Georgi, has shown anti-inflammatory and antioxidant activities, while mesenchymal stem cells (MSCs) have the capability of self-renewal and multilineage differentiation. In the present study, we found that baicalin could promote differentiation of bone marrow-derived MSCs into hepatocytes in vitro. We then compared the therapeutic effects of five therapeutic regimens for hepatic fibrosis induced by carbon tetrachloride in vivo by analysis of serum enzymes, morphological characteristics, cytokines and cell engraftment. Transplantation of MSCs alone was able to promote partial recovery of liver function and suppression of liver inflammation, but showed little effect on reducing the fibrotic area; transplantation with baicalin-treated MSCs gave an improved therapeutic effect; MSC transplantation and baicalin administration showed a synergistic effect; transplantation with baicalin-treated MSCs in combination with baicalin administration had the best therapeutic effect for hepatic fibrosis. Therefore, we conclude that transplantation of pre-differentiated MSC together with baicalin administration may serve as an effective therapeutic regimen for severe liver diseases.

摘要

从黄芩(Scutellaria baicalensis Georgi)根中分离得到的黄芩苷已显示出抗炎和抗氧化活性,而间充质干细胞(MSCs)具有自我更新和多向分化的能力。在本研究中,我们发现黄芩苷能够在体外促进骨髓来源的间充质干细胞向肝细胞分化。然后,我们通过分析血清酶、形态学特征、细胞因子和细胞植入情况,比较了五种治疗方案对四氯化碳诱导的体内肝纤维化的治疗效果。单独移植间充质干细胞能够促进肝功能部分恢复并抑制肝脏炎症,但对减少纤维化面积效果甚微;移植经黄芩苷处理的间充质干细胞具有更好的治疗效果;间充质干细胞移植与黄芩苷给药显示出协同作用;移植经黄芩苷处理的间充质干细胞并联合黄芩苷给药对肝纤维化具有最佳治疗效果。因此,我们得出结论,预分化的间充质干细胞移植联合黄芩苷给药可能是治疗严重肝脏疾病的有效治疗方案。

相似文献

1
A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin.一种使用间充质干细胞和黄芩苷联合治疗肝纤维化的新型治疗方案。
Pharmazie. 2011 Jan;66(1):37-43.
2
Therapeutic potential of bone-marrow-derived mesenchymal stem cells differentiated with growth-factor-free coculture method in liver-injured rats.无生长因子共培养法诱导骨髓间充质干细胞向肝系细胞分化的治疗潜能在肝损伤大鼠中的研究。
Tissue Eng Part A. 2010 Aug;16(8):2649-59. doi: 10.1089/ten.TEA.2009.0814.
3
Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis.在硫代乙酰胺诱导的肝硬化大鼠模型中骨髓间充质干细胞的肝向分化。
Cell Biol Int. 2012 Mar 1;36(3):279-88. doi: 10.1042/CBI20110325.
4
Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.预处理间充质干细胞与转化生长因子-α可改善间充质干细胞介导的心脏保护作用。
Shock. 2010 Jan;33(1):24-30. doi: 10.1097/SHK.0b013e3181b7d137.
5
Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.间质干细胞输注疗法在四氯化碳诱导的肝纤维化模型中影响基质金属蛋白酶的表达。
Cell Biol Int. 2010 Apr 27;34(6):601-5. doi: 10.1042/CBI20090386.
6
Coencapsulation of hepatocytes with bone marrow mesenchymal stem cells improves hepatocyte-specific functions.肝细胞与骨髓间充质干细胞共包封可改善肝细胞的特异性功能。
Transplantation. 2009 Nov 27;88(10):1178-85. doi: 10.1097/TP.0b013e3181bc288b.
7
Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.用生长因子组合对间充质干细胞进行预处理可增强缝隙连接形成、对心肌细胞的细胞保护作用以及对心肌梗死的治疗效果。
J Am Coll Cardiol. 2008 Mar 4;51(9):933-43. doi: 10.1016/j.jacc.2007.11.040.
8
No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury.在长期肝损伤大鼠模型中,多能间充质基质细胞对肝脏再生无贡献。
Stem Cells. 2007 Mar;25(3):639-45. doi: 10.1634/stemcells.2006-0515. Epub 2006 Nov 16.
9
Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats.区域肝照射后骨髓间充质干细胞移植可改善硫代乙酰胺诱导的大鼠肝纤维化。
J Surg Res. 2014 Jan;186(1):408-16. doi: 10.1016/j.jss.2013.08.016. Epub 2013 Sep 11.
10
Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats.大鼠肝纤维化过程中造血干细胞向肝细胞的分化
Transplant Proc. 2006 Nov;38(9):3082-5. doi: 10.1016/j.transproceed.2006.08.132.

引用本文的文献

1
Mesenchymal stem cell therapy for liver fibrosis need "partner": Results based on a meta-analysis of preclinical studies.间充质干细胞治疗肝纤维化需要“伙伴”:基于临床前研究的荟萃分析结果。
World J Gastroenterol. 2024 Aug 28;30(32):3766-3782. doi: 10.3748/wjg.v30.i32.3766.
2
Effectiveness and mechanisms of mesenchymal stem cell therapy in preclinical animal models of hepatic fibrosis: a systematic review and meta-analysis.间充质干细胞疗法在肝纤维化临床前动物模型中的有效性及机制:一项系统评价和荟萃分析
Front Bioeng Biotechnol. 2024 Jul 22;12:1424253. doi: 10.3389/fbioe.2024.1424253. eCollection 2024.
3
The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis.
间充质干细胞程序性细胞死亡对肝纤维化发展的影响
Stem Cells Int. 2023 May 11;2023:4586398. doi: 10.1155/2023/4586398. eCollection 2023.
4
Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis.提高间充质干细胞移植逆转肝纤维化效率的策略。
J Cell Mol Med. 2019 Mar;23(3):1657-1670. doi: 10.1111/jcmm.14115. Epub 2019 Jan 11.
5
Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters.茵陈蒿汤通过调节Ⅱ相代谢酶和转运体改善α-萘异硫氰酸酯诱导的大鼠肝内胆汁淤积
Front Pharmacol. 2018 May 15;9:510. doi: 10.3389/fphar.2018.00510. eCollection 2018.
6
Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases.间质干细胞依赖的肝脏疾病调控
Int J Biol Sci. 2017 Sep 5;13(9):1109-1117. doi: 10.7150/ijbs.20240. eCollection 2017.
7
Baicalin ameliorates renal fibrosis via inhibition of transforming growth factor β1 production and downstream signal transduction.黄芩苷通过抑制转化生长因子β1的产生和下游信号转导来改善肾纤维化。
Mol Med Rep. 2017 Apr;15(4):1702-1712. doi: 10.3892/mmr.2017.6208. Epub 2017 Feb 16.
8
Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathway.黄芩苷通过腺苷A2a受体相关的转化生长因子-β1诱导的细胞外信号调节激酶1/2信号通路减轻博来霉素诱导的肺纤维化。
BMC Pulm Med. 2016 Sep 23;16(1):132. doi: 10.1186/s12890-016-0294-1.
9
Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Liver Fibrosis in Rats.人羊膜间充质干细胞移植改善大鼠肝纤维化
Transplant Direct. 2015 May 26;1(4):e16. doi: 10.1097/TXD.0000000000000525. eCollection 2015 May.
10
Baicalein reduces the occurrence of cirrhotic endotoxemia by reducing intestinal mucosal apoptosis.黄芩素通过减少肠黏膜细胞凋亡降低肝硬化内毒素血症的发生。
BMC Complement Altern Med. 2015 May 29;15:161. doi: 10.1186/s12906-015-0682-8.